Study attributes and levels
| Effect category . | Attribute . | Levels . |
|---|---|---|
| Benefits | Chance of no symptoms of SCD after treatment | 90% (9/10) 80% (8/10) 60% (6/10)∗ 40% (4/10)∗ No chance† |
| Increase in life years after treatment | 8 more years 4 more years No increase | |
| Risks | Chance of death within 1 y after treatment | No chance 10% (1/10) 30% (3/10) |
| Increase in lifetime cancer risk | No increase Not expected Not known |
| Effect category . | Attribute . | Levels . |
|---|---|---|
| Benefits | Chance of no symptoms of SCD after treatment | 90% (9/10) 80% (8/10) 60% (6/10)∗ 40% (4/10)∗ No chance† |
| Increase in life years after treatment | 8 more years 4 more years No increase | |
| Risks | Chance of death within 1 y after treatment | No chance 10% (1/10) 30% (3/10) |
| Increase in lifetime cancer risk | No increase Not expected Not known |